Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
1.500
+0.290 (23.97%)
At close: Jul 13, 2026, 4:00 PM EDT
1.490
-0.010 (-0.67%)
After-hours: Jul 13, 2026, 7:46 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $35.89 million as of July 13, 2026. Its market cap has decreased by -68.57% in one year.
Market Cap
35.89M
Enterprise Value
25.60M
1-Year Change
-68.57%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $35.89M, a decrease of -76.41%. That is a compound annual growth rate of -52.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 35.89M | -74.77% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 32.08M |
| Kyntra Bio | 30.79M |
| Tvardi Therapeutics | 30.77M |
| Daré Bioscience | 30.26M |
| GridAI Technologies | 29.94M |
| Lisata Therapeutics | 29.78M |
| Actinium Pharmaceuticals | 29.18M |
| Plus Therapeutics | 27.53M |